JV
Jeffrey V. Poulton
DELAYED 1 MONTH
Director; EVP, Chief Financial Officer
ALNYLAM PHARMACEUTICALS, INC.
CervoMed Inc.
Filings
3
Companies
2
Latest
Jun 8, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
68
ALNYCLUSTER 5
ALNYLAM PHARMACEUTICALS, INC.
Jeffrey V. Poulton
EVP, Chief Financial Officer
Sale
$797.4K
2,468 sh
Mar 6 9:12 PM
Mar 4, 2026
64
ALNYCLUSTER 3
ALNYLAM PHARMACEUTICALS, INC.
Jeffrey V. Poulton
EVP, Chief Financial Officer
Sale
$722.8K
2,206 sh
Mar 5 12:31 AM
Mar 2, 2026